Accession Number: | 0001209191-21-056860 |
Date: | 2021-09-17 |
Issuer: | ALBIREO PHARMA, INC. (ALBO) |
Original Submission Date: |
COOPER RONALD HAROLD WILFRED
C/O ALBIREO PHARMA INC.
10 POST OFFICE SQUARE, SUITE 1000
BOSTON, MA 02109
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-09-17 | M | 11,973 | a | $19.19 | 68,433 | direct | ||
COMMON STOCK | 2021-09-17 | F | 7,760 | d | $29.61 | 60,673 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 19.19 | 2021-09-17 | deemed execution date | M | 11,973 (d) | 2027-01-19 | common stock 11,973 | $19.19 | 43,027 | direct |
ID | footnote |
---|---|
f1 | on september 17, 2021, the reporting person exercised options to purchase 11,973 shares of common stock and delivered 7,760 shares of common stock held by the reporting person to the issuer to pay the exercise price of the options. the delivery of the shares by the reporting person to pay the exercise price of the options was previously approved by the issuer's compensation committee in accordance with rule 16b-3 and the issuer has retained the shares delivered to it by the reporting person. |
f2 | represents 19,733 shares of common stock and 48,700 restricted stock units. |
f3 | represents 11,973 shares of common stock and 48,700 restricted stock units. |
f4 | this option is fully vested. |